These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease. Real E; Roca MJ; Viñuales A; Pastor E; Grau E Haematologica; 1999 Jul; 84(7):667-8. PubMed ID: 10406918 [No Abstract] [Full Text] [Related]
3. [Radiographic pulmonary changes after bleomycin therapy]. Kolmannskog F; Sortland O Tidsskr Nor Laegeforen; 1973 Mar; 93(9):579-82. PubMed ID: 4128184 [No Abstract] [Full Text] [Related]
4. Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure. Bennett WM; Pastore L; Houghton DC Cancer Treat Rep; 1980; 64(8-9):921-4. PubMed ID: 6160913 [TBL] [Abstract][Full Text] [Related]
7. Reversible pulmonary injury after a small dose of bleomycin. McCusker K; Dorman RA; Nicholson DP; Hough AJ South Med J; 1983 Nov; 76(11):1447-9. PubMed ID: 6195739 [TBL] [Abstract][Full Text] [Related]
8. Prospective study of the pulmonary toxicity of continuously infused bleomycin. Cooper KR; Hong WK Cancer Treat Rep; 1981; 65(5-6):419-25. PubMed ID: 6165471 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary function assessment during bleomycin therapy. Lampert-Benignus E; Eichler-Reiss F; Meunier-Carius J; Keiling R Biomed Pharmacother; 1985; 39(2):87-93. PubMed ID: 2410052 [TBL] [Abstract][Full Text] [Related]
11. Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors. Livingston RB; Bodey GP; Gottlieb JA; Frei E Cancer Chemother Rep; 1973 Apr; 57(2):219-24. PubMed ID: 4126382 [No Abstract] [Full Text] [Related]
13. Bleomycin in the treatment of metastatic cancer. Depierre A Prog Biochem Pharmacol; 1976; 11():195-204. PubMed ID: 63964 [No Abstract] [Full Text] [Related]
14. On the pathogenesis of bleomycin lung toxicity. Pozzi E; Zanon P Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):575-8. PubMed ID: 83311 [TBL] [Abstract][Full Text] [Related]
15. Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma. Al-Jizani WA; Al-Mansour MM; Al-Fayea TM; Shafi RU; Kazkaz GA; Bayer AM; Al-Foheidi ME; Ibrahim EM Future Oncol; 2015; 11(15):2149-57. PubMed ID: 26235180 [TBL] [Abstract][Full Text] [Related]
16. The place of bleomycin in the treatment of highly differentiated squamous cell cancer either alone or in combination with irradiation. Rygård J; Hansen HS Prog Biochem Pharmacol; 1976; 11():205-18. PubMed ID: 63966 [No Abstract] [Full Text] [Related]
17. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman. Ahmed BM; Al-Zakwani IS J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168 [TBL] [Abstract][Full Text] [Related]